The Medical Device Market: Brazil

Publisher Name :
Date: 29-Jan-2014
No. of pages: 217

Overview

Brazil has the largest economy and medical device market in Latin America, but per capita medical expenditure is still very low. The highest expenditure is in the large cities, such as São Paulo or Rio de Janeiro, but producers are moving into regional markets outside the major state capitals. The medical device market in 2013 is valued at US$5,918.9mn, equal to US$29.6 per capita.

The public health system (SUS), created in 1988, provides healthcare services to around 75% of the population and the private sector 25%. However, the majority of inpatient services within the SUS are operated by private providers, with more than two-thirds of hospital facilities operated by the private sector. Further private investment in the health sector is being encouraged through a public-private partnership scheme launched in 2008, which is supported by the International Finance Corporation, the Brazilian Development Bank and the Inter-American Development Bank.

Brazil has the second largest private health insurance sector in the Americas, after the USA, covering around 25% of the population, 48mn people, in 2012. The expansion of the private health insurance sector in recent years has resulted in demand for better medical care and, in turn, further expenditure in medical equipment. The economic downturn has not affected hospital capital investments so severely. The public sector continues to be modernised and to upgrade obsolete equipment, therefore there are sizeable market opportunities if prices are competitive.

The government is extending healthcare service access through its Mais Saúde programme launched at the end of 2007, phase 2 of which is set to run until 2014. This programme has focused attention on developing the primary care network.

The government continues to invest in the expansion of the SUS. In 2013, BRL2.3bn (US$1.1bn) will be invested to support the development of primary health and emergency care services. A total of BRL$1.39bn (US$662mn) has also been invested in university hospitals since 2010 under the National University Hospital Restructuring programme (REHUF), which aims to improve access and quality of tertiary services provided to patients as well as the working and training conditions of medical students.

Medical device mports hold a relatively small share of the market, totalling US$2.8bn in 2012. They increased by 8.0% in 2012, but the CAGR 2007-2012 was much higher at 14.8%. Imports tend to be hightech medical equipment not produced locally. In 2012, over 75% of imports were supplied by Europe and the USA.

Brazilian medical device exports totalled US$524.6mn in 2012, a fall of 5.4% over 2011. The country has a well-established medical industry, comprising local and multinational companies. Domestic production, however, is geared towards the local market. Exports are small in comparison with total production and the country consistently runs a negative balance of trade in medical equipment and supplies.

The Medical Device Market: Brazil

Table of Contents

Espicom Industry View   7
Espicom Industry View      7
SWOT     9
Medical Device Market      9
Political     10
Economic    11
Business Environment     12
Industry Forecast     13
Medical Device Market Forecast    13
Past Performance 2008-2013    13
Future Performance 2013-2018    14
Table: Projected Medical Device Market, 2013-2018     15
Table: Detailed Medical Device Market By Product Area, 2008-2018 (US$mn)   16
Table: Detailed Medical Device Market By Product Area, 2008-2018 (US$ Per Capita)  20
Table: Detailed Medical Device Market By Product Area, 2008-2018 (% Of Total)     23
Table: Detailed Medical Device Market By Product Area, 2009-2018 (US$mn, % Change)  26
Consumables Market Forecast    29
Table: Consumables Market, 2008-2018 (US$mn)  31
Table: Consumables Market, 2008-2018 (US$ Per Capita)    32
Table: Consumables Market, 2009-2018 (US$mn % Change)    33
Diagnostic Imaging Market Forecast     35
Electrodiagnostic Apparatus Sector   36
Radiation Apparatus Sector     37
Imaging Parts & Accessories Sector     38
Table: Diagnostic Imaging Market, 2008-2018 (US$mn)     38
Table: Diagnostic Imaging Market, 2008-2018 (US$ Per Capita)   39
Table: Diagnostic Imaging Market, 2009-2018 (US$mn % Change)     40
Dental Products Market Forecast   42
Table: Dental Products Market, 2008-2018 (US$mn)     44
Table: Dental Products Market, 2008-2018 (US$ Per Capita)  44
Table: Dental Products Market, 2009-2018 (US$mn % Change)     45
Orthopaedics & Prosthetics Market Forecast  47
Table: Orthopaedics & Prosthetics Market, 2008-2018 (US$mn)   48
Table: Orthopaedics & Prosthetics Market, 2008-2018 (US$ Per Capita)   49
Table: Orthopaedics & Prosthetics Market, 2009-2018 (US$mn % Change)      49
Patient Aids Market Forecast     51
Table: Patient Aids Market, 2008-2018 (US$mn)    52
Table: Patient Aids Market, 2008-2018 (US$ Per Capita)   53
Table: Patient Aids Market, 2009-2018 (US$mn % Change)   53
Other Medical Devices Market Forecast    55
Table: Other Medical Devices Market, 2008-2018 (US$mn)   56
Table: Other Medical Devices Market, 2008-2018 (US$ Per Capita)  57
Table: Other Medical Devices Market, 2009-2018 (US$mn % Change)      58
Annual Medical Device Imports     60
Table: Medical Device Imports By Product Area, 2008-2012 (US$000s)      64
Table: Medical Device Imports By Product Area, 2008-2012 (US$000s, % Change)  65
Table: Medical Device Imports By Product Area, 2008-2012 (Local Currency 000s)     66
Table: Medical Device Imports By Product Area 2008-2012 (Local Currency 000s, % Change)   67
Table: Medical Device Imports By Product Area 2008-2012 (% Distribution)   68
Table: Leading Medical Device Suppliers By Product Area, 2012 (US$000s)   71
Table: Leading Medical Device Suppliers By Product Area, 2012 (% Distribution)     72
Table: Top 20 Medical Device Suppliers, 2012 (US$000s)    73
Table: Detailed Medical Device Imports By Product Area, 2008-2012 (US$000s)  74
Table: Detailed Medical Device Import Trends By Product Area, 2012      77
Table: Detailed Leading Medical Device Suppliers By Product Area, 2012 (US$000s)  81
Monthly Medical Device Imports    85
Table: Monthly Medical Device Imports By Product Area, October 2010 - September 2013 (US$mn)      85
Annual Medical Device Exports     87
Table: Medical Device Exports By Product Area, 2008-2012 (US$000s)      89
Table: Medical Device Exports By Product Area, 2008-2012 (US$000s, % Change)  90
Table: Medical Device Exports By Product Area 2008-2012, (Local Currency 000s)     91
Table: Medical Device Exports By Product Area, 2008-2012 (Local Currency 000s, % Change)      92
Table: Medical Device Exports By Product Area, 2008-2012 (% Distribution)      94
Table: Leading Medical Device Destinations By Product Area, 2012 (US$000s)      97
Table: Leading Medical Device Destinations By Product Area, 2012 (% Distribution)  98
Table: Top 20 Medical Device Destinations, 2012 (US$000s)  99
Table: Detailed Medical Device Exports By Product Area, 2008-2012 (US$000s)  100
Table: Detailed Medical Device Export Trends By Product Area, 2012   103
Table: Detailed Leading Medical Device Destinations By Product Area, 2012 (US$000s)     107
Table: Detailed Medical Device Balance Of Trade, 2008-2012 (US$000s)   110
Monthly Medical Device Exports     114
Table: Monthly Medical Device Exports By Product Area, October 2010 - September 2013 (US$mn)  114
Macroeconomic Forecasts  116
Table: Brazil - Economic Activity     122
Industry Risk Reward Ratings      123
Industry Risk Reward Ratings   123
Table: Espicom Analysis Of The Medical Device Market, 2013     123
Market Overview     125
Medical Device Market Overview     125
Overview     125
Table: Medical Device Market, Key Ratios, 2013  127
The Market In 2013     127
Table: Medical Device Market By Product Area, 2013   128
Healthcare Overview     131
Healthcare System      131
Main World Bank Health-Related Projects  132
Health Insurance   133
Health Expenditure     134
Medical Device Technology    134
Table: Medical Device Technology By Type, 2005-2012     135
Key Data     137
Table: Key Data, 2008-2013  137
Industry Trends And Developments   140
Industry Trends & Developments     140
Table: Funding Allocation For Elective Surgery By State, July 2013  143
Regulatory Development  151
Medical Device Regulations     151
Medical Device Pricing & Reimbursement   155
Competitive Landscape   157
Domestic Medical Device Production    157
Table: Medical Device Manufacturers By Type, 2005-2011   158
Table: Electromedical & Radiology Equipment Manufacturers By Type, Key Indicators, 2011   159
Table: Medical & Surgical Instrument Manufacturers By Type, Key Indicators, 2011  159
Table: Medical Supplies Manufacturers By Type, Key Indicators, 2011   161
Table: Medical Device Production By Type, 2007-2011 (BRL000)  162
Table: Medical Device Production By Type, 2007-2011 (US$000)  165
Domestic Medical Device Manufacturing    169
Table: Medical Device Industry Economic Data, 2005-2011 (US$mn)      169
National Medical Device Manufacturers     171
Table: Cremer Net Revenues, 2011 - June 2013 (BRLmn)    173
Multinational Medical Device Manufacturers  182
Multinational Market Activity   192
Table: Multinational Market Activity, 2013  192
Medical Device Market Access     195
Market Environment     195
Distribution     196
Mercosur     196
Import Duties & Taxes     197
Table: CET for Medical Devices as at 25th April 2012   197
Trade Associations      204
Table: ABIMED Members, 2013     204
Trade Fairs     207
Methodology     210
Table: Used HS Trade Codes, 2013     211
Table: Rearranged HS Trade Codes, 2013    213

  • Challenges in the Tourism Industry in Thailand
    Thailand has always been a popular tourist destination and tourism provides a major boost to the country’s economy. Bangkok, Hua Hin, Krabi, Samui, Phuket and Cha Am are some of the most attractive tourist destinations in the country. In 2012, Thailand had a very high number of arrivals. Even the number of Thai citizens who [...]
  • Future of the US Consumer Electronics Market
    The market for consumer electronics has been growing steadily. Some of the factors that are contributing to the growth in the market are technological advancement, rise in disposable income and increasing demand for new products. During 2012, consumer electronics market in the US demonstrated positive expansion, although the growth rate slowed down considerably following the [...]
  • Overview of the Global Retail Market
    The global retail industry continued to grow despite the difficult economic conditions in the world. In the fiscal year of 2011, sales-weighted, currency-adjusted revenue rose by 5.1% to $4.271 trillion for the world’s top 250 retailers. According to GRDI (Global Retail Development Index), in 2013 Brazil occupied the top spot in retail development. Chile and [...]
  • Bright Future Predicted for the Tourism Industry in Singapore
    Travel and tourism industry in Singapore has been growing at a steady rate and is considered to be a major contributor to the economic growth of the country. In 2012, Singapore’s IVA (International Visitors Arrivals) reached a record high of 14.5 million, with a growth rate of 10.1% year-on-year. In recent years, inbound travel to [...]
  • Potential of Staffing Market in United States
    The staffing industry places individuals into contract, temporary and permanent positions in firms around the world. Major staffing markets include France, Spain, Italy and Japan as well as many emerging markets. Temporary staffing around the world has been growing, but in US temporary market has been flat since 2006. The majority of staffing revenue majorly [...]
  • Graft-Versus-Host Disease (GVHD) Treatment Market worth $407 million by 2018
  • The graft-versus-host disease (GVHD) treatment market value will increase from $297 million in 2013 to $407 million by 2018, at a Compound Annual Growth Rate (CAGR) of 6.59%, according to research and consulting firm GlobalData. The company’s latest report* states …

  • Poland Pharmaceutical Industry Growing at 8.3% CAGR to 2020
  • Factors such as the growing elderly population, increasing availability of affordable medicines, and transparent regulatory guidelines will provide the necessary impetus for the growth of the Polish pharmaceutical market, but a decrease in mark-up prices and the country’s stringent drug …

  • Asia-Pacific, Led by China, Drive the Global Methanol Industry
  • China is driving the global methanol industry, with tremendous demand from both its energy and petrochemicals sectors. It accounts for 87.9% of Asia-Pacific’s (APAC) methanol capacity, and 51.9% of the global methanol capacity. Despite a large planned capacity increase in …

  • Diagnostic X-ray Imaging Market worth $4.0 billion by 2020
  • GlobalData estimates that the global diagnostic X-ray imaging market, worth $2.4 billion in 2012, will reach almost $4.0 billion by 2020, increasing at a Compound Annual Growth Rate (CAGR) of 6.7% during the forecast period. Many players are active in …

  • Graft-Versus-Host Disease Market Forecast to 2023
  • Graft-versus-host disease (GVHD) is a common complication of allogeneic hematopoietic stem cell transplantation (HSCT) that occurs when the donated (graft) cells are rejected and attack the host’s cells as foreign. GVHD can progress from mild to severe forms as either …

  • Non-Hodgkin Lymphoma Therapeutics in Major Developed Markets to 2020 – New Entrants and Promising Pipeline Widen Targeted and Immunotherapeutic Treatment Options
    Published: 29-Oct-2014        Price: US $4995 Onwards        
    GBI Research, a leading business intelligence provider, has released its latest research report: “Non-Hodgkin Lymphoma Therapeutics in Major Developed Markets to 2020 - New Entrants and Promising Pipeline Widen Targeted and Immunotherapeutic Treatment Options”, which provides in-depth insight into the indication. It provides estimates of market size for 2013 along with forecasts until 2020 for the eight major developed markets, which comprises the US, UK, France, Germany, Italy, Spain, Japan......
  • Cell Expansion Market by Product (Reagent, Media, Serum, Bioreactors, Centrifuge), Cell Type (human, animal), Application (Stem Cell Research, Regenerative Medicine, Clinical Diagnostics), End User (Hospital, Biotechnology, Cell Bank) – Forecast to 2019
    Published: 29-Oct-2014        Price: US $4650 Onwards        Pages: 224
    The global cell expansion market is expected to reach $14.8 billion by 2019 from $6.0 billion in 2014, growing at a CAGR of 19.7% from 2014 to 2019. The global cell expansion market is categorized on the basis of product, cell type, application, end user, and geography. The human cell expansion segment is expected to register the highest growth rate in the cell expansion market, by cell type, during the forecast period. Its favorable growth is attributed to increasing focus on human stem cell re......
  • Aortic Stent Grafts – Current and Future Players
    Published: 29-Oct-2014        Price: US $3500 Onwards        Pages: 106
    Aortic stent grafts are most commonly used to reinforce a weak spot in an artery, which is known as an aneurysm. The stent grafts are designed to seal tightly with the patient’s native artery above and below the aneurysm, and are used to treat abdominal aortic aneurysms as well as thoracic aortic aneurysms. Aortic aneurysms, as opposed to aneurysms found elsewhere in the body, are potentially very serious, as a burst aorta results in massive internal bleeding that can be fatal unless treated r......
  • Identifying and Commercializing First-in-Class Innovation in Non-Small-Cell Lung Carcinoma
    Published: 29-Oct-2014        Price: US $6995 Onwards        
    Large Degree of Innovation in NSCLC Pipeline The NSCLC pipeline currently has 389 products in active development across all stages, but a stark contrast between the mechanisms of action employed in the current market and the pipeline is evident. Where the market comprises primarily ineffective chemotherapies that target tubulin or DNA replication, the pipeline shows an incredibly diverse range of therapies targeting multiple signaling pathways and molecules integral to cancer development. Thi......
  • Global Biologic Therapeutics Market 2014-2018
    Published: 29-Oct-2014        Price: US $3500 Onwards        Pages: 185
    Biologic therapeutics include virus, therapeutic serum, toxin, allergenic product, antitoxin, blood component or derivative, vaccine, blood, protein (except any chemically synthesized polypeptide), or analogous product, or arsphenamine or derivative of arsphenamine (or any other trivalent organic arsenic compound), intended for the prevention, treatment, or cure of a disease or condition. These products differ from small molecules in terms of molecular weight, structure, synthesis, and immunogen......
  • Egypt Pharmaceuticals and Healthcare Report Q4 2014
    Published: 29-Oct-2014        Price: US $1295 Onwards        Pages: 126
    BMI View: Egypt's relative political stability will lead to a pickup in growth over the coming quarters, increasing the attractiveness of the pharmaceutical market - for which our forecast has been revised slightly upwards. The government's increased emphasis on developing the pharmaceutical sector and the announced expansion of the Medicare healthcare programme are positive developments this quarter. The challenges faced by pharmaceutical companies wishing to operate in the market are the c......
  • Global Pharmaceutical Packaging Market 2014-2018
    Published: 29-Oct-2014        Price: US $2500 Onwards        Pages: 77
    A pharmaceutical product is any chemical substance formulated or compounded as a single active ingredient. The packaging of medicines is a very complex process, and because of its molecular and chemical structure, it needs to be packed in an extremely durable material so that it could reach the customer in a desirable condition. The evolution of new diseases and increased health awareness have brought a transformation in the Pharmaceutical Packaging market. The vendors in the Global Pharmaceutic......
  • Indonesia Pharmaceuticals and Healthcare Report Q4 2014
    Published: 29-Oct-2014        Price: US $1295 Onwards        Pages: 142
    BMI View: Indonesia is one of the most promising markets for the pharmaceutical and healthcare companies in South East Asia. The country's large population, positive economic outlook and considerable disease burden bode well for growth in demand for drugs, medical devices and healthcare services. The ongoing implementation of the universal healthcare scheme in Indonesia coupled with the impending launch of the ASEAN Economic Community will provide growth opportunities for pharmaceutical firm......
  • Global Polymerase Chain Reaction (PCR) Market 2014-2018
    Published: 29-Oct-2014        Price: US $2500 Onwards        Pages: 75
    Polymerase Chain Reaction (PCR) is a technique of molecular genetics, which allows amplification and analysis of nucleic acid. It is very precise, specific and accurate technique used to amplify a specific DNA target from a mixture of DNA molecules. It is used in a wide array of applications in research and diagnosis, including genetic engineering, cloning, sequencing, diagnosis, genotyping, and many other areas. Advances in PCR technology and tools provide high reproducibility within a short pe......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs